Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 29 May 2019
      ‘Three more months is a lot if you have six months to live’
 
 
A blog by Bettina Ryll
 
Bettina Ryll, a medically-trained scientist, started the Melanoma Patient Network Europe after her husband died of the disease. She knows the value of extending survival and improving quality of life.

‘Unless you have experienced a terminal cancer diagnosis, you have no concept of what three more months would mean at the end of your life,’ said Dr Ryll. ‘When you’re not sick, three months seems like nothing. When you know your time is limited, three months can mean a lot, especially when the quality of life is good.’

Dr Ryll was asked for her view of a WHO technical report on the pricing of cancer medicines which was critical of the cost of drugs that add around three months to patients’ lives.
Read more →
 
 
      Blog
 
  29 May 2019 R&D: Why the EU bank invests in (patented) ideas (Guest blog)

A favourable IP environment is essential to compensate for the disadvantages that life sciences companies face when...

Read more →
 
 
 
      Videos
 
 
 
European Excellence: Making the EU a world leader in medical R&D
We want Europe to be the world leader in medical R&D. The pharmaceutical industry created a trade surplus of €79.7 billion for the European economy and we are continuing to invest. Read the full EFPIA Manifesto at: https://efpia.eu/manifesto/
 
 
Health For All: Bringing innovative health solutions to all patients
#WeWontRest until we bring innovative health solutions to all patients.
 
 
 
 
 
Stronger Together: Joining forces to fast-track results
Collaboration makes us stronger. Together we can transform the lives of patients - it is why #WeWontRest.
 
 
Protect The Spark
Every new treatment or cure starts with the spark of an idea. That spark has to be nurtured and cared for through the long and complex process of developing a medicine before it can begin to transform the lives of patients.
 
 
 
 
      Events
 
 
27 JUN 2019
  EFPIA 2019 Annual Conference Radisson Blu Royal Hotel, Brussels, Belgium

Making connections can advance patient care and support the European economy at a time of significant change and challenge...

Learn more →
 
 
 
18 JUN 2019
  EFPIA Oncology Data Summit: Unleashing the potential of data to improve cancer care... Brussels

The Summit will bring together cancer and data players from around Europe to actively participate in identifying the...

Learn more →
 
 
 
12 JUN 2019
  IMI Stakeholder Forum 2019 Royal Museums of Fine Arts of Belgium

Brain health and disease in the digital era - 2020 and beyond

Learn more →
 
 
 
23 JUN 2019
  WIN 2019 Symposium Paris, France

A symposium dedicated to Innovation and global deployment of Precision Oncology

Learn more →
 
 
      Building a healthier future for Europe
Manifesto: Building a healthier future for Europe 06 September 2018 (Publications)
Together we can transform the lives of patients - it is why #WeWontRest
Read more →
 
      What we are reading
IMI2 - Call 18 & 19 webinars 28 May 2019  (Innovative Medicines Initiative) Read more →
IMI pool of patient experts 28 May 2019  (Innovative Medicines Initiative) Read more →
AMR incentives could be next big EU opportunity, pharma boss says 29 May 2019  (Euractiv) Read more →
Unlocking the potential of cancer data: the Oncology Data Summit 29 May 2019  (Politico Europe) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
▶ in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe